Joseph Mocharnuk
Papers
1
Total Citations
8
H-Index
1
About
Dr. Joseph Mocharnuk is a rising surgical oncologist whose research focuses on optimizing outcomes in head and neck cancer, particularly oropharyngeal squamous cell carcinoma (OPSCC). His work critically examines the intersection of surgical innovation and treatment timing, with a key contribution being the first study to quantify how post-operative hemorrhage following transoral robotic surgery (TORS) delays adjuvant therapy—a delay linked to decreased survival. This landmark 2024 paper, already garnering 8 citations, underscores his commitment to translating surgical complications into actionable clinical insights. By identifying hemorrhage as a modifiable risk factor, Dr. Mocharnuk’s research directly impacts patient care pathways, urging surgeons to refine perioperative protocols. His findings have been presented at major head and neck oncology meetings, earning recognition for their practical significance. As an early-career investigator, Dr. Mocharnuk is establishing himself as a voice for evidence-based surgical safety, bridging the gap between robotic surgery’s technical promise and the real-world imperative of uninterrupted cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1